Table 1.
TRX-hFAS fusions | Partial activities, nmol/min
per mg
|
Fatty acids, cpm | |||||
---|---|---|---|---|---|---|---|
AT | MT | DH | KR | ER | TE | ||
DI-ID-N | 752 | 594 | 119 | 685 | |||
ID-C-DII-III | 1,158 | 43 | 98 | 90 | |||
DI | 475 | 257 | ND | 32 | |||
DII-III | 630 | 68 | 80 | 72 | |||
DI-ID-N + ID-C-DII-III | 24,750* | ||||||
DI-ID-N + DII-III | 240 | ||||||
DI + ID-C-DII-dIII | 46 | ||||||
DI + DII-III | 31 |
The construction of TRX-hFAS fusion plasmids is described in Materials and Methods and in Fig. 2. The expression of recombinant proteins in E. coli, purified by using TALON resin, and the determination of partial activities, were performed as described (23, 24). The reconstitution of FAS activities from the various recombinant halves of the human FAS subunits and the determination of fatty acid synthesis were carried out by using [2-14C] malonyl-CoA, acetyl-CoA, and NADPH as substrates (24). AT, acetyl transacylase; MT, malonyl transacylase; DH, β-hydroxyacyl dehydratase; KR, β-ketoacyl reductase; ER, enoyl reductase; ND, not determined.
These counts represent 9.8 nmol of fatty acids synthesized.